USPTO Examiner LUSI ELLIS FOLLETT - Art Unit 1677

Recent Applications

Detailed information about the 100 most recent patent applications.

Application NumberTitleFiling DateDisposal DateDispositionTime (months)Office ActionsRestrictionsInterviewAppeal
18404228ASSAY FOR RAPID DETECTION OF CEREBROSPINAL FLUID LEAKSJanuary 2024August 2025Allow2010YesNo
18447974BIOSENSOR SYSTEM WITH INTEGRATED MICRONEEDLEAugust 2023April 2025Allow2011NoNo
18319157METHODS AND RELATED ASPECTS FOR DETECTING UNLABELED BIOMOLECULESMay 2023January 2026Allow3300YesNo
18176144DEVICES AND METHODS OF URINALYSIS FOR REAL-TIME MONITORING OF ORGAN HEALTHFebruary 2023September 2024Allow1920YesNo
18099226DETECTION OF SARS-COV-2 PROTEINS AND MITOCHONDRIAL PROTEINS IN PLASMA NEURON-DERIVED EXTRACELLULAR VESICLES AND ASTROCYTE-DERIVED EXTRACELLULAR VESICLESJanuary 2023July 2025Abandon3021NoNo
18088996Method and System for Exposing Hidden or Masked Antigenic Sites of Viral Specimens Present in Biosamples Using a Home-Based COVID-19 Rapid Lateral Flow Immunoassay TestDecember 2022July 2025Allow3022YesNo
17987181IMMUNOCHROMATOGRAPHIC DETECTION DEVICENovember 2022March 2024Allow1610NoNo
18046911Mask-Based Diagnostic System using Exhaled Breath CondensateOctober 2022June 2025Allow3211YesNo
17949157MEMBRANE BASED CHEMILUMINESCENCE IMMUNOCHROMATOGRAPHY ASSAY AND ITS USESeptember 2022March 2026Abandon4240YesNo
17882671COMPOSITIONS, KITS, AND METHODS FOR DETECTING PRECLINICAL ALZHEIMER'S DISEASEAugust 2022November 2025Allow3950YesNo
17813204DEVICES AND METHODS FOR MINIMIZING HOOK EFFECT INTEFERENCE IN IMMUNOASSAYSJuly 2022June 2025Allow3530YesNo
17835238ASSAY FOR RAPID DETECTION OF CEREBROSPINAL FLUID LEAKSJune 2022October 2023Allow1700YesNo
17780508PROSTATE CANCER BIOMARKERSMay 2022December 2025Abandon4301NoNo
17774395METHOD FOR DIAGNOSING HUMAN T-CELL LEUKEMIA VIRUS TYPE 1 (HTLV-1)-RELATED DISEASEMay 2022February 2026Allow4621YesNo
17713181SEQUENTIAL LATERAL FLOW DEVICEApril 2022February 2025Allow3520YesNo
17628022ANTIBODY SPECIFICALLY BINDING TO WRS PROTEIN, AND USE THEREOFJanuary 2022February 2026Allow4911YesNo
17577066OVERACTIVE BLADDER DIAGNOSTIC APPARATUS AND METHODSJanuary 2022October 2024Abandon3211NoNo
17560074ANTIGEN DETECTION METHOD AND KIT WITH FALSE POSITIVE SIGNAL REMOVEDDecember 2021November 2024Allow3530NoNo
17511975DETECTION DEVICE USING LATERAL FLOW STRIP FOR DETECTION AND DETECTION METHOD THEREOFOctober 2021April 2024Allow3001YesNo
17598837USE OF A PS396 ASSAY TO DIAGNOSE TAUOPHATIESSeptember 2021May 2025Abandon4401NoNo
17481806REGENERABLE AFFINITY SENSORS AND ASSOCIATED METHODSSeptember 2021September 2024Allow3611YesNo
17441386BIOMARKER CEREBLON FOR DIAGNOSING HEPATOCELLULAR CARCINOMA, AND NOVEL MONOCLONAL ANTIBODY SPECIFIC THERETOSeptember 2021July 2025Allow4611YesNo
17459158METHOD FOR DETECTING TARGET SUBSTANCE, REAGENT FOR DETECTING TARGET SUBSTANCEAugust 2021October 2024Allow3811YesNo
17432700METHODS OF DETECTING SEPTIC ARTHRITIS, TRANSIENT SYNOVITIS AND OSTEOMYELITISAugust 2021May 2025Allow4511NoNo
17395330COMPOSITIONS AND METHODS FOR DETECTION AND TREATMENT OF CORONAVIRUS INFECTIONAugust 2021November 2024Allow3911YesNo
17310289SENSOR CHIP AND METHODS THEREOFJuly 2021September 2025Allow4911YesNo
17425197METHOD AND KIT FOR DISCRIMINATING BETWEEN PARKINSON'S DISEASE AND MULTIPLE SYSTEM ATROPHYJuly 2021July 2024Allow3610YesNo
17310054BIOMARKERSJuly 2021October 2025Abandon5121YesNo
17368116COMPOSITIONS AND METHODS FOR CHARACTERIZING ARTHRITIC CONDITIONSJuly 2021December 2025Abandon5320YesNo
17326472COMPETITIVE LATERAL FLOW ASSAYMay 2021August 2024Abandon3911NoNo
17292224Diagnosing Sepsis or Bacteremia by Detecting Peptidoglycan Associated Lipoprotein (PAL) in UrineMay 2021April 2024Abandon3511NoNo
17244636VELVET DISEASE TEST AND METHODApril 2021September 2024Abandon4110NoNo
17214996SPECIMEN PREPARATION DEVICEMarch 2021October 2024Abandon4201NoNo
17277880IMMUNOCHROMATOGRAPHIC TEST STRIPMarch 2021January 2026Allow5741YesNo
17277098Composition and Methods for Measuring Antibody DynamicsMarch 2021June 2025Allow5021YesNo
17195600Analytical Toilet for Assessing Analytes in ExcretaMarch 2021December 2024Abandon4501NoNo
17189711Mask-Based Diagnostic System using Exhaled Breath CondensateMarch 2021August 2025Allow5311YesNo
17269152SORBENT COMPOSITION FOR PRE-ANALYTICAL TREATMENT OF SAMPLESFebruary 2021August 2025Allow5410YesNo
17268637METHOD FOR PURIFYING ANTIBODY OR ANTIBODY-LIKE MOLECULEFebruary 2021November 2024Allow4520YesNo
17268480APPLICATIONS OF SERUM S100A8/A9 COMPLEX LEVEL IN PROGNOSIS ASSESSMENT OF ACUTE MYOCARDIAL INFARCTIONFebruary 2021November 2025Abandon5731YesNo
17268006Use of Reagent for Detecting Expression Level of Transferrin in Preparation of Diagnostic Reagent or Kit for Disease Caused by Imbalance of Intestinal Immune ToleranceFebruary 2021August 2024Abandon4211NoNo
17174268MONOCLONAL ANTIBODIES BINDING MCM5February 2021March 2025Abandon4911NoNo
17250609METHODS AND COMPOSITIONS FOR REMOVING BIOTIN INTERFERENCE FROM ASSAYS USING MOLECULAR TRAPSFebruary 2021November 2024Allow4520YesNo
17159589LATERAL FLOW IMMUNOASSAY DEVICE WITH SEPARATION MEMBRANEJanuary 2021September 2025Allow5550NoNo
17150997ELECTROPHORETIC SYSTEM AND METHOD FOR ANALYTE CAPTUREJanuary 2021May 2025Allow5221YesNo
17248236SPECIES-SPECIFIC ANTIGEN SEQUENCES FOR TICK-BORNE RELAPSING FEVER (TBRF) AND METHODS OF USEJanuary 2021March 2026Allow6051YesNo
17142739AIRBORNE CORONAVIRUS DETECTOR AND ALERTING SYSTEMJanuary 2021November 2024Abandon4621YesNo
17117131TEST STRIP, AND MICROBIAL SENSOR DEVICE AND SENSING METHODDecember 2020October 2024Abandon4621NoNo
17111616MODIFIED PARTICLE, METHOD FOR MANUFACTURING MODIFIED PARTICLE, AND DETECTION APPARATUSDecember 2020July 2025Abandon5631YesNo
17104059Biosensor System with Integrated MicroneedleNovember 2020June 2024Allow4321NoNo
17087372CONCENTRATION ASSAYNovember 2020March 2024Abandon4010YesNo
17082223SYSTEMS AND METHODS FOR SAMPLE PREPARATIONOctober 2020November 2025Abandon6032NoNo
17065488Mask-Based Testing System for Detecting Biomarkers in Exhaled Breath Condensate, Aerosols and GasesOctober 2020June 2025Allow5611YesNo
17043961IN VITRO SCREENING METHOD AND KIT FOR EARLY DIAGNOSIS OF ORAL CAVITY TUMOURSSeptember 2020June 2024Abandon4401NoNo
17021671REAGENT KIT AND MEASUREMENT KIT FOR SERUM AMYLOID ASeptember 2020May 2024Allow4320YesNo
16997369MICROCHIP IMMUNOASSAY DEVICE HAVING PRECISE INCUBATION TIME CONTROL AND SIGNAL SCALING AND RELATED METHODSAugust 2020March 2024Abandon4330YesNo
16964870ASSAYING CELLS AND NON-CELL ANALYTES IN A SAMPLE IN PARALLELJuly 2020October 2023Allow3940YesNo
16932532MULTIPLEX LATERAL FLOW ASSAY FOR DIFFERENTIATING BACTERIAL INFECTIONS FROM VIRAL INFECTIONSJuly 2020October 2023Allow3951YesNo
16932533MULTIPLEX LATERAL FLOW ASSAY FOR DIFFERENTIATING BACTERIAL INFECTIONS FROM VIRAL INFECTIONSJuly 2020November 2023Allow4050YesNo
16882447Using Exhaled Breath Condensate, Aerosols and Gases for Detecting BiomarkersMay 2020June 2024Allow4941YesNo
16876054Using Exhaled Breath Condensate for Testing for a Biomarker of COVID-19May 2020February 2024Allow4531YesNo
16753661METHODS OF DETECTING TRANSTHYRETINApril 2020October 2024Allow5511YesNo
16834474SYSTEM AND METHOD FOR DETECTING PATHOGENS ON TREATED AND UNTREATED SUBSTRATES USING LIQUID CRYSTAL CHROMONIC AZO DYEMarch 2020September 2025Abandon6040NoNo
16616923SINGLE-STEP ATPS ENHANCED LFA DIAGNOSTIC DESIGNNovember 2019February 2026Abandon6061YesNo
16656658EFFICIENT CAPTURE OF MAGNETIC AND PARAMAGNETIC CARRIERS OF BIOMARKERS FROM A FLOWING SYSTEMOctober 2019May 2024Abandon5431NoNo
16492431IMMUNOCHROMATOGRAPHIC DEVICE FOR EXTRACTING AND MEASURING SUGAR CHAIN ANTIGENSeptember 2019March 2026Abandon6042NoNo
16484035QMAX ASSAY AND APPLICATIONS (II)August 2019November 2024Allow6061YesNo
16308145IMMUNOCHROMATOGRAPHIC TEST PIECE AND SPECIMEN ADDING DEVICE FOR EXTRACTING AND MEASURING SUGAR CHAIN ANTIGEN, AND IMMUNOCHROMATOGRAPHY METHOD USING SAMEDecember 2018October 2024Allow6051YesNo
16144533FLUID TEST CARTRIDGE, FLUID TEST APPARATUS INCLUDING THE SAME, AND METHOD FOR CONTROLLING THE FLUID TEST APPARATUSSeptember 2018September 2024Allow6051YesNo
15779933ELECTROMAGNETIC ASSEMBLIES FOR PROCESSING FLUIDSMay 2018April 2024Abandon6051YesNo

Appeals Overview

No appeal data available for this record. This may indicate that no appeals have been filed or decided for applications in this dataset.

Examiner LUSI, ELLIS FOLLETT - Prosecution Strategy Guide

Executive Summary

Examiner LUSI, ELLIS FOLLETT works in Art Unit 1677 and has examined 53 patent applications in our dataset. With an allowance rate of 56.6%, this examiner allows applications at a lower rate than most examiners at the USPTO. Applications typically reach final disposition in approximately 46 months.

Allowance Patterns

Examiner LUSI, ELLIS FOLLETT's allowance rate of 56.6% places them in the 17% percentile among all USPTO examiners. This examiner is less likely to allow applications than most examiners at the USPTO.

Office Action Patterns

On average, applications examined by LUSI, ELLIS FOLLETT receive 2.36 office actions before reaching final disposition. This places the examiner in the 67% percentile for office actions issued. This examiner issues a slightly above-average number of office actions.

Prosecution Timeline

The median time to disposition (half-life) for applications examined by LUSI, ELLIS FOLLETT is 46 months. This places the examiner in the 10% percentile for prosecution speed. Applications take longer to reach final disposition with this examiner compared to most others.

Interview Effectiveness

Conducting an examiner interview provides a +52.1% benefit to allowance rate for applications examined by LUSI, ELLIS FOLLETT. This interview benefit is in the 94% percentile among all examiners. Recommendation: Interviews are highly effective with this examiner and should be strongly considered as a prosecution strategy. Per MPEP § 713.10, interviews are available at any time before the Notice of Allowance is mailed or jurisdiction transfers to the PTAB.

Request for Continued Examination (RCE) Effectiveness

When applicants file an RCE with this examiner, 18.6% of applications are subsequently allowed. This success rate is in the 18% percentile among all examiners. Strategic Insight: RCEs show lower effectiveness with this examiner compared to others. Consider whether a continuation application might be more strategic, especially if you need to add new matter or significantly broaden claims.

After-Final Amendment Practice

This examiner enters after-final amendments leading to allowance in 23.8% of cases where such amendments are filed. This entry rate is in the 32% percentile among all examiners. Strategic Recommendation: This examiner shows below-average receptiveness to after-final amendments. You may need to file an RCE or appeal rather than relying on after-final amendment entry.

Petition Practice

When applicants file petitions regarding this examiner's actions, 23.5% are granted (fully or in part). This grant rate is in the 12% percentile among all examiners. Strategic Note: Petitions are rarely granted regarding this examiner's actions compared to other examiners. Ensure you have a strong procedural basis before filing a petition, as the Technology Center Director typically upholds this examiner's decisions.

Examiner Cooperation and Flexibility

Examiner's Amendments: This examiner makes examiner's amendments in 0.0% of allowed cases (in the 3% percentile). This examiner rarely makes examiner's amendments compared to other examiners. You should expect to make all necessary claim amendments yourself through formal amendment practice.

Quayle Actions: This examiner issues Ex Parte Quayle actions in 0.0% of allowed cases (in the 3% percentile). This examiner rarely issues Quayle actions compared to other examiners. Allowances typically come directly without a separate action for formal matters.

Prosecution Strategy Recommendations

Based on the statistical analysis of this examiner's prosecution patterns, here are tailored strategic recommendations:

  • Prepare for rigorous examination: With a below-average allowance rate, ensure your application has strong written description and enablement support. Consider filing a continuation if you need to add new matter.
  • Prioritize examiner interviews: Interviews are highly effective with this examiner. Request an interview after the first office action to clarify issues and potentially expedite allowance.
  • Plan for extended prosecution: Applications take longer than average with this examiner. Factor this into your continuation strategy and client communications.

Relevant MPEP Sections for Prosecution Strategy

  • MPEP § 713.10: Examiner interviews - available before Notice of Allowance or transfer to PTAB
  • MPEP § 714.12: After-final amendments - may be entered "under justifiable circumstances"
  • MPEP § 1002.02(c): Petitionable matters to Technology Center Director
  • MPEP § 1004: Actions requiring primary examiner signature (allowances, final rejections, examiner's answers)
  • MPEP § 1207.01: Appeal conferences - mandatory for all appeals
  • MPEP § 1214.07: Reopening prosecution after appeal

Important Disclaimer

Not Legal Advice: The information provided in this report is for informational purposes only and does not constitute legal advice. You should consult with a qualified patent attorney or agent for advice specific to your situation.

No Guarantees: We do not provide any guarantees as to the accuracy, completeness, or timeliness of the statistics presented above. Patent prosecution statistics are derived from publicly available USPTO data and are subject to data quality limitations, processing errors, and changes in USPTO practices over time.

Limitation of Liability: Under no circumstances will IronCrow AI be liable for any outcome, decision, or action resulting from your reliance on the statistics, analysis, or recommendations presented in this report. Past prosecution patterns do not guarantee future results.

Use at Your Own Risk: While we strive to provide accurate and useful prosecution statistics, you should independently verify any information that is material to your prosecution strategy and use your professional judgment in all patent prosecution matters.